Study finds measuring non-clinical influences on FDA approvals is complex

A new study examined how non-clinical factors might affect the U.S. Food and Drug Administration's drug approval decisions.

Researchers concluded that quantifying such influences is challenging because the factors are often indirect, undocumented, and vary across applications.

The findings underscore the need for more transparent processes and better tools if regulators and industry want to assess potential external impacts on approval outcomes.